These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3894171)
41. The short-term effects of Eudragit-L-coated prednisolone metasulphobenzoate (Predocol) on bone formation and bone mineral density in acute ulcerative colitis. Darlow SJ; Mandal A; Pick B; Thomas T; Mayberry JF; Robinson RJ Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1173-6. PubMed ID: 15489578 [TBL] [Abstract][Full Text] [Related]
42. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Kumana CR; Seaton T; Meghji M; Castelli M; Benson R; Sivakumaran T Lancet; 1982 Mar; 1(8272):579-83. PubMed ID: 6121181 [TBL] [Abstract][Full Text] [Related]
43. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674 [TBL] [Abstract][Full Text] [Related]
44. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742 [TBL] [Abstract][Full Text] [Related]
45. Nicotine enemas for active ulcerative colitis--a pilot study. Green JT; Thomas GA; Rhodes J; Williams GT; Evans BK; Russell MA; Feyerabend C; Rhodes P; Sandborn WJ Aliment Pharmacol Ther; 1997 Oct; 11(5):859-63. PubMed ID: 9354193 [TBL] [Abstract][Full Text] [Related]
46. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Danielsson A; Löfberg R; Persson T; Salde L; Schiöler R; Suhr O; Willén R Scand J Gastroenterol; 1992; 27(1):9-12. PubMed ID: 1736348 [TBL] [Abstract][Full Text] [Related]
47. A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis. van Deventer SJ; Tami JA; Wedel MK Gut; 2004 Nov; 53(11):1646-51. PubMed ID: 15479686 [TBL] [Abstract][Full Text] [Related]
48. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468 [TBL] [Abstract][Full Text] [Related]
49. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Lindgren S; Löfberg R; Bergholm L; Hellblom M; Carling L; Ung KA; Schiöler R; Unge P; Wallin C; Ström M; Persson T; Suhr OB Scand J Gastroenterol; 2002 Jun; 37(6):705-10. PubMed ID: 12126250 [TBL] [Abstract][Full Text] [Related]
50. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon. Frühmorgen P; Demling L Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627 [TBL] [Abstract][Full Text] [Related]
51. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis. Hammond A; Andus T; Gierend M; Ecker KW; Scholmerich J; Herfarth H; Hepatogastroenterology; 2004; 51(59):1345-9. PubMed ID: 15362749 [TBL] [Abstract][Full Text] [Related]
52. Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone-21-phosphate enemata. MATTS SG Br Med J; 1961 Jan; 1(5220):165-8. PubMed ID: 13768326 [No Abstract] [Full Text] [Related]
54. Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis. Hawthorne AB; Record CO; Holdsworth CD; Giaffer MH; Burke DA; Keech ML; Hawkey CJ Gut; 1993 Jan; 34(1):125-8. PubMed ID: 8432442 [TBL] [Abstract][Full Text] [Related]
55. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Ruddell WS; Dickinson RJ; Dixon MF; Axon AT Gut; 1980 Oct; 21(10):885-9. PubMed ID: 7002739 [TBL] [Abstract][Full Text] [Related]
58. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
59. Local release of human neutrophil lipocalin (HNL), IL-8, and TNF-alpha is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis. Sangfelt P; Carlson M; Thörn M; Xu S; Lööf L; Raab Y Dig Dis Sci; 2002 Sep; 47(9):2064-9. PubMed ID: 12353856 [TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis. Green JT; Thomas GA; Rhodes J; Evans BK; Russell MA; Feyerabend C; Fuller GS; Newcombe RG; Sandborn WJ Clin Pharmacol Ther; 1997 Mar; 61(3):340-8. PubMed ID: 9084459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]